Elmira Jalilian | PhD, Health Science & Technology
Harvard Medical School | United States
Dr Elmira Jalilian is a Research Fellow at Harvard Medical School. Prior to this, Elmira did her Ph.D. in Stem Cell Biology and Regenerative Medicine at University College London (UCL), UK.
In her Ph.D. thesis, she studied the generation and characterization of iPSC-derived Endothelial Progenitor Cells (EPCs) and their molecular mechanisms during differentiation. She also investigated important signaling pathways that regulate endothelial cell phenotype during vascular regeneration.
She is now working at Brigham and Women’s Hospital, Harvard Medical School and working on development of novel 3D bio-printing technology to generate pre-vascularised muscle fibers with the aim of designing the next generation of scaffold for vascular tissue engineering constructs. Elmira holds a Master’s degree in Medical Genetic from Institute of Genetic Medicine,Newcastle University, and a bachelor’s degree in Cellular and Molecular Biology.
Appearances:
Cell Culture World Congress 24th May @ 11:40
Generation of iPS-derived Endothelial Cells and its application in stem cell tissue engineering approaches
Cell Culture Master- Differentiation of iPS-derived Endothelial Cells in vitro using 3D culture system.
- Characterisation of in vitro generated cells using Next Generation Sequencing.
- Developing novel hybrid materials and 3D bioprinting technology that can control endothelial cell function in pre-vascularised muscle constructs.
Organiser
